Effect of Metformin Treatment on Lipoprotein Subfractions in Non-Diabetic Patients with Acute Myocardial Infarction: A Glycometabolic Intervention as Adjunct to Primary Coronary Intervention in ST Elevation Myocardial Infarction (GIPS-III) Trial.
OBJECTIVE:Metformin affects low density lipoprotein (LDL) and high density (HDL) subfractions in the context of impaired glucose tolerance, but its effects in the setting of acute myocardial infarction (MI) are unknown. We determined whether metformin administration affects lipoprotein subfractions...
Main Authors: | Ruben N Eppinga, Minke H T Hartman, Dirk J van Veldhuisen, Chris P H Lexis, Margery A Connelly, Erik Lipsic, Iwan C C van der Horst, Pim van der Harst, Robin P F Dullaart |
---|---|
Format: | Article |
Language: | English |
Published: |
Public Library of Science (PLoS)
2016-01-01
|
Series: | PLoS ONE |
Online Access: | http://europepmc.org/articles/PMC4726568?pdf=render |
Similar Items
-
The Effect of Metformin on Diastolic Function in Patients Presenting with ST-Elevation Myocardial Infarction.
by: Lawien Al Ali, et al.
Published: (2016-01-01) -
Temporal Course of Plasma Trimethylamine N-Oxide (TMAO) Levels in ST-Elevation Myocardial Infarction
by: Mohammad A. Almesned, et al.
Published: (2021-12-01) -
Sex‐Based Differences in Unrecognized Myocardial Infarction
by: M. Yldau van der Ende, et al.
Published: (2020-07-01) -
Predictors of adverse diastolic remodeling in non-diabetic patients presenting with ST-elevation myocardial infarction
by: Lawien Al Ali, et al.
Published: (2023-01-01) -
Multi-Modality Imaging for Prevention of Coronary Artery Disease and Myocardial Infarction in the General Population: Ready for Prime Time?
by: Daan Ties, et al.
Published: (2022-05-01)